Recruitment

Recruitment Status
Active, not recruiting
Estimated Enrollment
45

Summary

Conditions
  • Contraception
  • Migraine
  • Migraine;Menstrual
Type
Interventional
Phase
Phase 1
Design
Allocation: N/AIntervention Model: Single Group AssignmentIntervention Model Description: Prospective, non-inferiority study to evaluate the pharmacokinetic effect of topiramate on serum ENG levels in contraceptive implant usersMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 45 years
Gender
Only males

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT03335163
Collaborators
Merck Sharp & Dohme Corp.
Investigators
Principal Investigator: Stephanie Teal, MD University of Colorado School of Medicine